A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women with Recurrent, Persistent or Metastatic Endometrial Cancer
For more information about this clinical trial, click here
Schema & Eligibility NRG-GY012
CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Mosaic Life Care, St. Joseph, MO
Ask your physician about participating in this clinical trial or call us.